Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-04

FDA Approved: QUETIAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a generic quetiapine product from Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (generic) (quetiapine fumarate)

Snippet

SUPPL AP for QUETIAPINE (QUETIAPINE)